TAKEDA PHARMACEUTICALS NORTH A has a total of 19 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are AWD PHARMA GMBH & CO KG, NEUROVANCE INC and MYLAN LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 4 | |
#3 | Canada | 3 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Argentina | 1 | |
#7 | China | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Lademacher Christopher | 8 |
#2 | Taneja Rajneesh | 7 |
#3 | Macdonald Patricia | 4 |
#4 | Ridge Nancy J | 3 |
#5 | Mcdonald Patricia | 3 |
#6 | Joseph-Ridge Nancy | 2 |
#7 | Lee Ronald L | 2 |
#8 | Gupte Vijay | 2 |
#9 | Berge Steve | 2 |
#10 | Vakily Majid | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010030988A1 | Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors | |
MX2009004984A | Methods for preserving renal function using xanthine oxidoreductase inhibitors. | |
EP1940397A2 | Methods for treating hypertension |